Feb 1 |
Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
|
Jan 27 |
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
|
Jan 24 |
Silo Pharma Announces Positive Results in Alzheimer’s Disease Study
|
Jan 23 |
Silo Pharma files for $25M mixed securities shelf
|
Jan 12 |
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
|
Jan 7 |
Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
|
Jan 4 |
Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD
|
Dec 28 |
Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia
|
Dec 11 |
Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
|
Dec 8 |
SHF Holdings And 3 Other Stocks Under $2 Insiders Are Buying
|